These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 24069219)
1. Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma. Yan B; Li H; Yang X; Shao J; Jang M; Guan D; Zou S; Van Waes C; Chen Z; Zhan M PLoS One; 2013; 8(9):e73656. PubMed ID: 24069219 [TBL] [Abstract][Full Text] [Related]
2. A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas. Lee TL; Yeh J; Friedman J; Yan B; Yang X; Yeh NT; Van Waes C; Chen Z Int J Cancer; 2008 May; 122(9):1987-98. PubMed ID: 18172861 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma. Yan B; Yang X; Lee TL; Friedman J; Tang J; Van Waes C; Chen Z Genome Biol; 2007; 8(5):R78. PubMed ID: 17498291 [TBL] [Abstract][Full Text] [Related]
4. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma. Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630 [TBL] [Abstract][Full Text] [Related]
5. Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cohen J; Chen Z; Lu SL; Yang XP; Arun P; Ehsanian R; Brown MS; Lu H; Yan B; Diallo O; Wang XJ; Van Waes C Cancer Res; 2009 Apr; 69(8):3415-24. PubMed ID: 19351843 [TBL] [Abstract][Full Text] [Related]
6. A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Lee TL; Yang XP; Yan B; Friedman J; Duggal P; Bagain L; Dong G; Yeh NT; Wang J; Zhou J; Elkahloun A; Van Waes C; Chen Z Clin Cancer Res; 2007 Oct; 13(19):5680-91. PubMed ID: 17908957 [TBL] [Abstract][Full Text] [Related]
7. Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status. Yan B; Chen G; Saigal K; Yang X; Jensen ST; Van Waes C; Stoeckert CJ; Chen Z Genome Biol; 2008; 9(3):R53. PubMed ID: 18334025 [TBL] [Abstract][Full Text] [Related]
8. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules. Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694 [TBL] [Abstract][Full Text] [Related]
9. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
10. p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Lin Y; Mallen-St Clair J; Luo J; Sharma S; Dubinett S; St John M Oral Oncol; 2015 Oct; 51(10):921-8. PubMed ID: 26306422 [TBL] [Abstract][Full Text] [Related]
11. Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. Nottingham LK; Yan CH; Yang X; Si H; Coupar J; Bian Y; Cheng TF; Allen C; Arun P; Gius D; Dang L; Van Waes C; Chen Z Oncogene; 2014 Feb; 33(9):1135-47. PubMed ID: 23455325 [TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Ondrey FG; Dong G; Sunwoo J; Chen Z; Wolf JS; Crowl-Bancroft CV; Mukaida N; Van Waes C Mol Carcinog; 1999 Oct; 26(2):119-29. PubMed ID: 10506755 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Ferris RL; Grandis JR Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953 [No Abstract] [Full Text] [Related]
14. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513 [TBL] [Abstract][Full Text] [Related]
15. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Allen CT; Ricker JL; Chen Z; Van Waes C Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170 [TBL] [Abstract][Full Text] [Related]
16. ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. Yang X; Lu H; Yan B; Romano RA; Bian Y; Friedman J; Duggal P; Allen C; Chuang R; Ehsanian R; Si H; Sinha S; Van Waes C; Chen Z Cancer Res; 2011 May; 71(10):3688-700. PubMed ID: 21576089 [TBL] [Abstract][Full Text] [Related]
17. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470 [TBL] [Abstract][Full Text] [Related]
18. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638 [TBL] [Abstract][Full Text] [Related]
20. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex. Verduci L; Ferraiuolo M; Sacconi A; Ganci F; Vitale J; Colombo T; Paci P; Strano S; Macino G; Rajewsky N; Blandino G Genome Biol; 2017 Dec; 18(1):237. PubMed ID: 29262850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]